Gilead Sciences, Inc. (ETR:GIS)
Germany · Delayed Price · Currency is EUR 101.18
+0.16 (0.16%)
Oct 10, 2025, 5:35 PM CET
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €125.09 billion as of October 10, 2025. Its market cap has increased by 36.37% in one year.
Market Cap
125.09B
Enterprise Value
139.62B
Revenue
24.58B
Ranking
n/a
PE Ratio
23.28
Stock Price
€101.18
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 125.09B, an increase of 64,218.41%. That is a compound annual growth rate of 21.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 125.09B | 12.50% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | 59.70B | -18.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 53.96B |
| Merck KGaA | 52.20B |
| Bayer Aktiengesellschaft | 27.70B |
| Fresenius SE & Co. KGaA | 27.12B |
| Fresenius Medical Care AG | 13.57B |
| Sartorius Aktiengesellschaft | 13.48B |
| Fielmann Group AG | 4.27B |
| Carl Zeiss Meditec AG | 3.86B |